National Bank of Canada
AVXL icon

National Bank of Canada’s Anavex Life Sciences AVXL Stock Holding History

National Bank of Canada’s Portfolio AVXL Stock Details AVXL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$4.59K Sell
1,500
-303,700
-100% -$1.32M ﹤0.01% 2476
2025
Q4 		$1.09M Sell
305,200
-87,971
-22% -$539K ﹤0.01% 1183
2025
Q3 		$3.5M Buy
393,171
+107,886
+38% +$1.09M ﹤0.01% 958
2025
Q2 		$2.63M Buy
285,285
+10,293
+4% +$87.9K ﹤0.01% 1086
2025
Q1 		$2.36M Buy
274,992
+273,992
+27,399% +$2.59M ﹤0.01% 1028
2024
Q4 		$10.7K Hold
1,000
– – ﹤0.01% 2312
2024
Q3 		$5.68K Sell
1,000
-22,500
-96% -$130K ﹤0.01% 2181
2024
Q2 		$96.6K Hold
23,500
– – ﹤0.01% 1496
2024
Q1 		$89.5K Buy
23,500
+22,487
+2,220% +$127K ﹤0.01% 1580
2023
Q4 		$6.12K Hold
1,013
– – ﹤0.01% 2259
2023
Q3 		$6.44K Hold
1,013
– – ﹤0.01% 2304
2023
Q2 		$8.22K Sell
1,013
-350
-26% -$3K ﹤0.01% 2236
2023
Q1 		$11.7K Hold
1,363
– – ﹤0.01% 2099
2022
Q4 		$12.6K Sell
1,363
-22,163
-94% -$237K ﹤0.01% 2118
2022
Q3 		$241K Hold
23,526
– – ﹤0.01% 1316
2022
Q2 		$235K Hold
23,526
– – ﹤0.01% 1370
2022
Q1 		$289K Hold
23,526
– – ﹤0.01% 1415
2021
Q4 		$408K Buy
+23,526
New +$447K ﹤0.01% 1292

Other funds holding AVXL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
SF
Summit Financial Parsippany, New Jersey $7.85B AUM 20.99% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

National Bank of Canada's AVXL Position: Q1 2026 in Review

National Bank of Canada reduced its Anavex Life Sciences (AVXL) stake by 100% in Q1 2026, selling an estimated $1.32M and leaving 1,500 shares worth $4.59K. The position accounts for ﹤0.01% of the portfolio, ranked #2476.

National Bank of Canada first reported a position in AVXL in Q4 2021 and has held it in 18 quarters since. The position peaked at $3.5M in Q3 2025. 190 funds tracked by Wall St. Rank hold AVXL as of Q1 2026.

  • National Bank of Canada held 1,500 shares of Anavex Life Sciences worth $4.59K as of Q1 2026.
  • National Bank of Canada sold 303,700 Anavex Life Sciences shares in Q1 2026, an estimated $1.32M.
  • Anavex Life Sciences made up ﹤0.01% of National Bank of Canada's portfolio in Q1 2026, its #2476 holding.
  • National Bank of Canada first reported a position in Anavex Life Sciences in Q4 2021 and has held it in 18 quarters since.
  • National Bank of Canada's Anavex Life Sciences position peaked at $3.5M in Q3 2025.
  • 190 funds tracked by Wall St. Rank held Anavex Life Sciences as of Q1 2026.

Based on National Bank of Canada's 13F filing for Q1 2026, filed 15 May 2026.